In the spleen of the BLM-induced SSc mouse model, the separate deletion of the TLR7 and TLR9 genes can independently inhibit the inflammatory response by elevating the ratio of IL-10 + CD19 + B cells. Here, CD19 is linked to systemic sclerosis.